Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations.
Charity D EvansRuth Ann MarrieFeng ZhuStella LeungXinya LuElaine KingwellYinshan ZhaoHelen TremlettPublished in: Pharmacoepidemiology and drug safety (2017)
Hospitalization rates were lower in subjects with optimal DMT adherence, but findings were not statistically significant. Prior hospitalization and polypharmacy were associated with increased risk for future hospitalizations in MS. Copyright © 2017 John Wiley & Sons, Ltd.